Table 3.
Cardiovascular characteristics of patients included in the study.
| All patients | Non- FLD | FLD | ||||||
|---|---|---|---|---|---|---|---|---|
| Non-FLD nor MD | Non-FLD with MD | non-MD FLD | MAFLD-MHO | MAFLD-MUHO | MAFLD-MD | MAFLD-T2D | ||
| n | 370 | 92 | 62 | 28 | 88 | 63 | 6 | 31 |
| VAT (mL) | 3659 ± 2058 | 2239 ± 1675 | 3933 ± 1770 | 1505 ± 926 | 3916 ± 1522 | 5272 ± 1932 | 3099 ± 1698 | 5376 ± 1462 |
| SCAT (mL) | 5300 ± 3096 | 4118 ± 1593 | 6166 ± 2417 | 3803.6 ± 1270.7 | 5310 ± 2204 | 6278 ± 2423 | 3816 ± 1129 | 6702 ± 7619 |
| VAT/SCAT Ratio | 0.74 ± 0.39 | 0.56 ± 0.39 | 0.70 ± 0.36 | 0.41 ± 0.25 | 0.80 ± 0.33 | 0.89 ± 0.29 | 0.84 ± 0.44 | 1.10 ± 0.43 |
| Mean EAT (mL) | 158.6 ± 91.2 | 107.9 ± 75.2 | 158.9 ± 84.2 | 94.5 ± 46.4 | 160.9 ± 69.8 | 222.7 ± 96.4 | 143.4 ± 82.8 | 232.7 ± 90.3 |
| EATi (mL) | 81.6 ± 42.5 | 59.6 ± 36.2 | 79.8 ± 38.1 | 55.9 ± 27.3 | 82.4 ± 33.4 | 109.3 ± 47.2 | 78.6 ± 39.9 | 116.2 ± 39.9 |
| Mean CAC Score (Agatston Score) | 73.1 ± 212.9 | 37.4 ± 121.1 | 54.3 ± 190.5 | 25.1 ± 74.4 | 63.1 ± 167.1 | 84.5 ± 180.9 | 27.5 ± 33.8 | 273.4 ± 486.3 |
Values are expressed as mean (SD), unless otherwise stated.
CAC, coronary artery calcium; FLD, fatty liver disease; MAFLD, metabolic dysfunction–associated fatty liver disease; EAT, epicardial adipose tissue; EATi, indexed epicardial adipose tissue; MD, metabolic dysfunction; MHO, metabolically healthy obesity; MUHO, metabolically unhealthy obesity; SCAT, subcutaneous adipose tissue; VAT, visceral adipose tissue.